Medtronic (MDT) Declares $0.305 Quarterly Dividend; 1.9% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
S&P Keeps Medtronic (MDT) on CreditWatch Negative Ahead of Covidien Deal Closing
August 21, 2014 5:14 PM EDTStandard & Poor's Ratings Services today said its ratings, including the 'AA-' corporate credit rating, on Medtronic Inc. (NYSE: MDT) remain on CreditWatch with negative implications, pending the planned acquisition of Covidien plc.
"The proposed transaction strengthens Medtronic's scale, product diversity, and market position, and... More
Medtronic, Inc. (MDT) Tops Q1 EPS by 1c
August 19, 2014 7:17 AM EDTMedtronic, Inc. (NYSE: MDT) reported Q1 EPS of $0.93, $0.01 better than the analyst estimate of $0.92. Revenue for the quarter came in at $4.27 billion versus the consensus estimate of $4.25 billion.
Medtronic, Inc. reaffirmed FY2014 guidance. Company also reaffirmed its commitment to Covidien transaction (NYSE:... More
